Shanghai Cell Diff Medicine Technology

Shanghai Cell-Diff Medicine Technology is a Chinese biotechnology company focused on the development of next-generation cell therapies derived from induced pluripotent stem cells (iPSCs). Founded by Dr. Li Xiang, a former senior scientist at Sana Biotechnology, the company leverages advanced cell differentiation technologies to create off-the-shelf therapeutic products for neurological and degenerative diseases. Its primary research focus includes the development of dopaminergic neurons for the treatment of Parkinson's disease and other central nervous system disorders. The company aims to overcome the limitations of traditional cell therapies by providing standardized, scalable, and highly functional cell products. Shanghai Cell-Diff is currently in the pre-clinical stage, advancing its lead programs toward IND-enabling studies.